Lenalidomide and Eltrombopag for Treatment in Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Study Combination Clinical Trial
Jesus D. Gonzalez-Lugo,Suman Kambhapati,Abdulraheem Yacoub,William Donnellan,Prafulla Bhagat,Karen Fehn,Cassady Remy,Sakshi Jasra,Mohammad Kazemi,Ioannis Mantzaris,R. Alejandro Sica,Lizamarie Bachier-Rodriguez,Mendel Goldfinger,Noah Kornblum, Kira Gristman,Ira Braunschweig,Ulrich G. Steidl,Britta Will,Aditi Shastri,Amit Verma Blood(2021)
关键词
intermediate risk myelodysplastic syndrome,eltrombopag,clinical trial
AI 理解论文
溯源树
样例